Register to get unlimited Level 2

Ireland, Netherlands suspend AstraZeneca vaccine over blood clot risks

By Caoimhe Toman

Date: Monday 15 Mar 2021

Ireland, Netherlands suspend AstraZeneca vaccine over blood clot risks

(Sharecast News) - The Irish and the Dutch governments were the latest to join the list of countries that have halted the Oxford-AstraZeneca vaccination programme until the risk of blood clots is ruled out, even as Europe's main drugs regulator said the benefits of the shot continued to outweigh the risks.
The Dutch government said Sunday that the Oxford-AstraZeneca vaccine would not be used until at least 29 March, while Ireland said earlier that same day that it had temporarily suspended the shot as a precautionary step.

The World Health Organization downplayed the risks last week when it said that there was no link between the shot and an increased risk of developing blood clots. The statement was backed by the European Medicines Agency.

Amsterdam and Dublin's halt came after Norway's medicines agency said it had been notified of three health workers being treated in hospital for bleeding, blood clots and a low count of blood platelets after receiving the Oxford-AstraZeneca vaccine.

"A careful review of all available safety data of more than 17m people vaccinated in the European Union (EU) and UK with Covid-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country," AstraZeneca said in a statement on Sunday.

The European Medicines Agency agreed, saying in a statement on Monday: ""Many thousands of people develop blood clots annually in the EU for different reasons.

"The number of thromboembolic events overall in vaccinated people seems not to be higher than that seen in the general population."

It also recommended that vaccinations continue while the latest data was reviewed.

Only 30 people from 5.0m who had been vaccinated had had issues.

A meeting of the EMA to evaluate the latest data was scheduled for Thursday.



..

Email this article to a friend

or share it with one of these popular networks:


Top of Page